Chai Discovery

Chai Discovery
AI-powered drug discovery platform using foundation models for molecular design.
About
What does Chai Discovery do?
Chai Discovery, founded in 2024 (OpenAI-backed, incubated in OpenAI offices), builds foundation models for predicting biochemical interactions. Raised $130M Series B at $1.3B valuation (Dec 2025). Partnership with Eli Lilly for drug development.
What is Chai Discovery's revenue?
StartupHub estimates Chai Discovery's annual revenue at $644.1M (range $422.2M to $678.6M, 42% confidence), based on comparable companies in the sector.
What is Chai Discovery's valuation?
StartupHub estimates Chai Discovery's effective valuation at $3.9B (range $2.7B to $5.1B, 41% confidence), based on comparable companies in the sector.
How much funding has Chai Discovery raised?
Chai Discovery has raised a total of $872M in funding. The most recent round on record is Series C.
Where is Chai Discovery headquartered?
Chai Discovery is headquartered in San Francisco, United States.
When was Chai Discovery founded?
Chai Discovery was founded in 2023.
What industry does Chai Discovery operate in?
Chai Discovery operates in Artificial Intelligence, Biotechnology, Drug Discovery, Molecular Design, Foundation Models, NeoLab.
No comments yet. Be the first to share your take.
